Role of annexin A5 in tumor and basic research on the target of it

［1］ Peng B, Guo C, Guan H, et al. Annexin A5 as a potential marker in tumors［J］. Clin Chim Acta, 2014, 427: 42-48. DOI: 10.1016/j.cca.2013.09.048. ［2］ Carmeille R, Degrelle SA, Plawinski L, et al. AnnexinA5 promotes membrane resealing in human trophoblasts［J］. Biochim Biophys Acta, 2015, 1853(9): 2033-2044. DOI: 10.1016/j.bbamcr.2014.12.038. ［3］ Bouter A, Carmeille R, Gounou C, et al. Review: annexinA5 and cell membrane repair［J］. Placenta, 2015, 36 Suppl 1: S43-S49. DOI: 10.1016/j.placenta.2015.01.193. ［4］ Rand JH, Wu XX, Lin EY, et al. Annexin A5 binds to lipopolysaccharide and reduces its endotoxin activity［J］. MBio, 2012, 3(2): e00292-11. DOI: 10.1128/mBio.00292-11. ［5］ Arnold P, Lu X, Amirahmadi F, et al. Recombinant human annexin A5 inhibits proinflammatory response and improves cardiac function and survival in mice with endotoxemia［J］. Crit Care Med, 2014, 42(1): e32-e41. DOI: 10.1097/CCM.0b013e3182a63e01. ［6］ Gu C, Liu M, Zhao T, et al. Recombinant human annexin A5 can repair the disrupted cardiomyocyte adherens junctions in endotoxemia［J］. Shock, 2015, 44(1): 83-89. DOI: 10.1097/SHK.0000000000000370. ［7］ Brazier SP, Telezhkin V, Kemp PJ. Functional interactions between BKCaαsubunit and annexin A5: implications in apoptosis［J］. Oxid Med Cell Longev, 2016, 2016: 1607092. DOI: 10.1155/2016/1607092. ［8］ Hong M, Park N, Chun YJ. Role of annexin a5 on mitochondriadependent apoptosis induced by tetramethoxystilbene in human breast cancer cells［J］. Biomol Ther (Seoul), 2014, 22(6): 519-524. DOI: 10.4062/biomolther.2014.112. ［9］ Zhu Y, Liu Y, Qian Y, et al. Research on the efficacy of celastrus orbiculatus in suppressing TGFβ1induced epithelialmesenchymal transition by inhibiting HSP27 and TNF-αinduced NFκB/snail signaling pathway in human gastric adenocarcinoma［J］. BMC Complement Altern Med, 2014, 14: 433. DOI: 10.1186/1472-6882-14-433. ［10］ Li Y, Wang L, Kang A, et al. Screening and identification of proteins related to gastric cancer metastasis with comparative proteomics［J］. Nan Fang Yi Ke Da Xue Xue Bao, 2015, 35(3): 360-364. ［11］ Sun B, Bai Y, Zhang L, et al. Quantitative proteomic profiling the molecular signatures of ANXA5 in lung squamous carcinoma cells［J］. PLoS One, 2016, 11(9): e0163622. DOI: 10.1371/journal.pone.0163622. ［12］ Biswas SK. Metabolic reprogramming of immune cells in cancer progression［J］. Immunity, 2015, 43(3): 435-449. DOI: 10.1016/j.immuni.2015.09.001. ［13］ Payen VL, Porporato PE, Baselet B, et al. Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway［J］. Cell Mol Life Sci, 2016, 73(7): 1333-1348. DOI: 10.1007/s00018-0152098-5. ［14］王小杰, 杨艳杰, 田焕娜, 等. 膜联蛋白A5低表达对人宫颈癌 HeLa细胞迁移和侵袭的影响［J］. 解剖学报, 2016, 47(4): 487-492. DOI: 10.16098/j.issn.0529-1356.2016.04.009. ［15］ Sun X, Wei B, Liu S, et al. Anxa5 mediates the in vitro malignant behaviours of murine hepatocarcinoma HcaF cells with high lymph node metastasis potential preferentially via ERK2/p-ERK2/c-Jun/p-c-Jun (Ser73) and E-cadherin［J］. Biomed Pharmacother, 2016, 84: 645-654. DOI: 10.1016/j.biopha.2016.09.086. ［16］ Peng B, Liu S, Guo C, et al. ANXA5 level is linked to in vitro and in vivo tumor malignancy and lymphatic metastasis of murine hepatocarcinoma cell［J］. Future Oncol, 2016, 12(1): 31-42. DOI: 10.2217/fon.15.289. ［17］ Wu L, Yang L, Xiong Y, et al. Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells［J］. Tumour Biol, 2014, 35(12): 12327-12337. DOI: 10.1007/s13277-014-2545-1. ［18］ Gong LL, Zhao HQ, Wang L, et al. Upregulation of annexin A5 affects the biological behaviors of lung squamous carcinoma cells in vitro［J］. Chin Sci Bull, 2014, 59(28): 3610-3620. DOI: 10.1007/s11434-014-0301-y. ［19］ Jing J, Chen L, Fu HY, et al. Annexin Vinduced rat leydig cell proliferation involves Ect2 via RhoA/ROCK signaling pathway［J］. Sci Rep, 2015, 5: 9437. DOI: 10.1038/srep09437. ［20］ Shin DW, Kwon YJ, Ye DJ, et al. Auranofin suppresses plasminogen activator inhibitor2 expression through annexin A5 induction in human prostate cancer cells［J］. Biomol Ther (Seoul), 2017, 25(2): 177-185. DOI: 10.4062/biomolther.2016.223. ［21］ Stringer B, Udofa EA, Antalis TM. Regulation of the human plasminogen activator inhibitor type 2 gene: cooperation of an upstream silencer and transactivator［J］. J Biol Chem, 2012, 287(13): 10579-10589. DOI: 10.1074/jbc.M111.318758. ［22］ Wang J, Zhang Y, Liu X, et al. Annexin A5 inhibits diffuse large Bcell lymphoma cell invasion and chemoresistance through phosphatidylinositol 3kinase signaling［J］. Oncol Rep, 2014, 32(6): 2557-2563. DOI: 10.3892/or.2014.3547. ［23］ Wu L, Yang L, Xiong Y, et al. Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells［J］. Tumour Biol, 2014, 35(12): 12327-12337. DOI: 10.1007/s13277-014-2545-1. ［24］ Poon IK, Lucas CD, Rossi AG, et al. Apoptotic cell clearance: basic biology and therapeutic potential［J］. Nat Rev Immunol, 2014, 14(3): 166-180. DOI: 10.1038/nri3607. ［25］ Liu A, Ming JY, Fiskesund R, et al. Induction of dendritic cellmediated Tcell activation by modified but not native lowdensity lipoprotein in humans and inhibition by annexin a5: involvement of heat shock proteins［J］. Arterioscler Thromb Vasc Biol, 2015, 35(1): 197-205. DOI: 10.1161/ATVBAHA.114.304342. ［26］ Linke B, AbelerDrner L, Jahndel V, et al. The tolerogenic function of annexins on apoptotic cells is mediated by the annexin core domain［J］. J Immunol, 2015, 194(11): 5233-5242. DOI: 10.4049/jimmunol.1401299. ［27］ Berri F, Haffar G, Lê VB, et al. Annexin V incorporated into influenza virus particles inhibits gamma interferon signaling and promotes viral replication［J］. J Virol, 2014, 88(19): 11215-11228. DOI: 10.1128/JVI.01405-14. ［28］ Yan X, Doffek K, Yin C, et al. AnnexinV promotes antitumor immunity and inhibits neuroblastoma growth in vivo［J］. Cancer Immunol Immunother, 2012, 61(11): 19171927. DOI: 10.1007/s00262-012-1250-4. ［29］ Tiscia GL, Drum E, Myklebust CF, et al. Functional characterization of annexin A5 gene promoter allelic variants［J］. Thromb Res, 2016, 144: 9399. DOI: 10.1016/j.thromres.2016.06.009. ［30］ Wang C, Chen YW, Zhang L, et al. Melanoma cell surfaceexpressed phosphatidylserine as a therapeutic target for cationic anticancer peptide, temporin1CEa［J］. J Drug Target, 2016, 24(6): 548-556. DOI: 10.3109/1061186X.2015.1113539. ［31］ Guillen KP, Restuccia A, Kurkjian C, et al. Annexin Vdirected enzyme prodrug therapy plus docetaxel for the targeted treatment of pancreatic cancer［J］. Pancreas, 2015, 44(6): 945-952. DOI: 10.1097/MPA.0000000000000343. ［32］ Gieseler F, Gamperl H, Theophil F, et al. Using annexin Vcoated magnetic beads to capture active tissue factorbearing microparticles from body fluids［J］. Cell Biol Int, 2014, 38(2): 277-281. DOI: 10.1002/cbin.10216.

Role of annexin A5 in tumor and basic research on the target of it

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments